Can we use gonadotropin plasma concentration as surrogate marker for BMI-related incomplete estrogen suppression in breast cancer patients receiving anastrozole?
Crossref DOI link: https://doi.org/10.1186/s12885-017-3208-6
Published Online: 2017-03-28
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Oberguggenberger, A.
Meraner, V.
Sztankay, M.
Beer, B.
Weigel, G.
Oberacher, H.
Kemmler, G.
Czech, T.
Holzner, B.
Wildt, L.
Sperner-Unterweger, B.
Daniaux, M.
Hubalek, M. http://orcid.org/0000-0003-2346-7431